Stock listing

Purple Biotech Ltd.

Selected listing: A40NWE · LS · EUR · DE

Purple Biotech Ltd. (Lang & Schwarz: A40NWE), Health Technology. Latest release Apr 27, 2026: Purple Biotech Announces New Data from CAPTN-3 Platform…

A40NWE:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A40NWE
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Purple Biotech Ltd.

Purple Biotech Announces New Data from CAPTN-3 Platform Tri-specific IM1240

April 27, 2026

Purple Biotech Establishes Scientific Advisory Board to Support Development of CAPTN-3 Tri-Specific Antibody Platform

April 23, 2026

Purple Biotech Announces AI Collaboration with Converge Bio to Accelerate Development of its Next-Generation Tri-Specific Antibody Platform

March 25, 2026

Purple Biotech Regains Compliance with Nasdaq

March 17, 2026

Purple Biotech Announces CEO Transition

March 13, 2026

All Purple Biotech Ltd. news →

Research Purple Biotech Ltd.

Purple Biotech Ltd. company profile

View the public company page for Purple Biotech Ltd. on 6ix.

Purple Biotech Ltd. news

Read company news and market updates connected to Purple Biotech Ltd..

Purple Biotech Ltd. investor events

Find investor webinars, events, and replay context for Purple Biotech Ltd..